Shadow AI & Billion-Dollar Oncology Bets: The State of Enterprise Risk

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

Shadow AI & Billion-Dollar Oncology Bets: The State of Enterprise Risk

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

Enterprise AI adoption is outpacing governance at a scale that's no longer anecdotal — and a landmark Lenovo study puts hard numbers on the gap. Seventy percent of enterprise AI tools are running without IT oversight. One in three employees is actively using AI outside monitored channels. Sixty-one percent of IT leaders say AI-linked cyber threats are already rising, yet only thirty-one percent feel confident managing them. This is the shadow AI problem: structural, accelerating, and largely invisible to the organisations most exposed by it.

This episode maps the full shape of that risk — the difference between visibility and control, the attribution problem that makes incident response harder, and the organisational design challenge of retrofitting governance onto tools employees are already deeply embedded in.

The contrast comes from healthcare. Xaira Therapeutics has closed a one-billion-dollar funding round. A Sanofi and Insilico Medicine deal has reached one-point-two billion dollars. Both target AI-driven lung cancer therapeutics, where AI is now achieving between eighty-five and ninety-five percent accuracy in biomarker identification — a figure that changes what precision oncology can actually deliver. AI platforms are also compressing clinical trial timelines by optimising patient recruitment and running drug formulation in parallel.

The episode holds both signals together: enterprises losing control of AI already inside their walls, and a healthcare sector building AI into the architecture of drug discovery from day one. The gap between those two approaches is one of the clearest reads on where AI risk and AI opportunity are actually diverging right now.

This episode includes AI-generated content. A YesOui.ai Production.

This episode includes AI-generated content.

まだレビューはありません